Thrombosis and Haemostasis, Table of Contents Thromb Haemost 2004; 92(04): 676-677DOI: 10.1160/TH04-08-0490 Theme Issue Editorial Focus Schattauer GmbH New insights into paediatric haemostasis: thrombosis and bleeding issues Ulrike Nowak-Göttl 1 Paediatric Haematology/Oncology, University Children’s Hospital , Nicole Schlegel 2 Münster, Germany , Benjamin Brenner 3 Service D’Hématologie Biologique, Hôpital Robert Debré, Paris, France› Author AffiliationsRecommend Article Abstract Buy Article Full Text References References 1 Andrew M. Developmental hemostasis: Relevance to thromboembolic complications in pediatric patients. Thromb Haemost 1995; 74: 415-25. 2 Ehrenforth S, Junker R, Koch HG. et al. Multicentre evaluation of combined prothrombotic defects with thrombophilia in childhood. Eur J Pediatr 1999; 158: S97-S104. 3 Cvirn G, Gallistl S, Muntean W. Effects of antithrombin and protein C on thrombin generation in newborn and adult plasma. Thromb Res 1999; 93: 183-90. 4 Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 95: 936-43. 5 Van Ommen CH, Heijboer H, Buller HR. et al. Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands. J Pediatr 2001; 139: 676-81. 6 Brenner B, Sarig G, Wiener Z. et al. Thrombophilic polymorphisms are common in women with foetal loss without apparent cause. Thromb Haemost 1999; 82: 6-9. 7 Brenner B, Grabowski EF, Hellgren M. et al. Thrombophilia and pregnancy complications. Thromb Haemost 2004; 92: 678-81. 8 Rehak T, Cvirn G, Gallistl S. et al. Increased shear stressand ristocetin-induced binding of von Willebrand factor to platelets in cord compared with adult plasma. Thromb Haemost 2004; 92: 682-7. 9 Salonvaara M, Riikonen P, Vahtera E. et al. Development of selected coagulation factors and anticoagulants in preterm infants by the age of six months. Thromb Haemost 2004; 92: 688-96. 10 Kenet G, Sadetzki S, Murad H. et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischaemic stroke in children. Stroke 2000; 31: 1283-8. 11 Kosch A, Kuwertz-Bröking E, Heller C. et al. Renal venous thrombosis in neonates: Prothrombotic risk factors and long-term follow-up. Blood. 2004 May 18 [Epub ahead of print] PMID: 15150075. 12 Kirkham F, Sebire G, Steinlin M. et al. Arterial ischaemic stroke in children: review of the literature and strategies for future stroke studies. Thromb Haemost 2004; 92: 697-706. 13 Duering C, Kosch A, Langer C. et al. Total TFPI is an independent risk factor for symptomatic paediatric venous thromboembolism and stroke. Thromb Haemost 2004; 92: 707-12. 14 Kenet G, Waldman D, Lubetsky A. et al. Pediatric cerbral sinus vein thrombosis and thrombophilia - a multicenter case-controlled study. Thromb Haemost 2004; 92: 713-8. 15 Swarte R, Appel I, Lequin M. et al. Factor II gene (prothrombine G202102A) mutation and neonatal cerebrovenous thrombosis. Thromb Haemost 2004; 92: 719-21. 16 Kuhle S, Massicotte P, Chan A. et al. Systemic thromboembolism in children: data from the 1-800-NO-CLOTS consultation service. Thromb Haemost 2004; 92: 722-8. 17 Kuhle S, Massicotte P, Chan A, Mitchell L. A case series of 72 neonates with renal vein thrombosis: data from the 1-800-NO-CLOTS registry. Thromb Haemost 2004; 92: 729-33. 18 Ignatovic V, Barnes C, Newall F. et al. Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek Plus and Thrombotest methods with venous international normalised ratio. Thromb Haemost 2004; 92: 734-7. 19 Mathew P. The use of rFVIIa in non-hemophilia bleeding conditions in pediatrics: a systematic review. Thromb Haemost 2004; 92: 738-46.
